William Lubell
12Patents
2h-index
36Co-inventors
50Inventor score
Filing activity: Jun 11, 2002 → Jun 28, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7572913B2 | 4-substituted piperidine derivatives | Chemistry; Metallurgy | 123 | Expired |
| US7521530B2 | Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor | Human Necessities | 15 | Expired |
| US8618054B2 | Interleukin-1 receptor antagonists, compositions, and methods of treatment | Human Necessities | 2 | Expired |
| US8435954B2 | Azapeptides as CD36 binding compounds | Physics | 1 | Active |
| US8614233B2 | Cinnamoyl inhibitors of transglutaminase | Physics | 1 | Active |
| US9115171B2 | Azapeptides as CD36 binding compounds | Physics | 1 | Active |
| US8993515B2 | Peptidomimetics comprising N-amino cyclic urea residues and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9073963B2 | Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor | Human Necessities | 0 | Active |
| US11879021B2 | Cyclic peptides and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9708370B2 | Azapeptides as CD36 binding compounds | Physics | 0 | Active |
| US8802818B2 | Prostaglandin-F2 alpha receptor modulators and uses thereof | Human Necessities | 0 | Active |
| US9162991B2 | Cinnamoyl inhibitors of transglutaminase | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.